PRF Technologies (PRFX) Other financing activities (2021 - 2023)
PRF Technologies (PRFX) recorded quarterly Other financing activities of $1.6 million in Q4 2023, up 350.32% on a QoQ basis from -$620000.0 in Q3 2023.
PRF Technologies (PRFX) Other financing activities (2021 - 2023) Analysis & Trends
PRF Technologies has disclosed Other financing activities across 2 years of filings, most recently posting $1.6 million for Q4 2023.
- Quarterly Other financing activities changed N/A year-over-year to $1.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $486000.0 (changed N/A YoY) and the FY2025 annual result came in at $190000.0, down 84.62% from the prior year.
- Other financing activities rose to $1.6 million in Q4 2023, from -$620000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $1.6 million in Q4 2023 and troughed at -$620000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.55 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | -620,000.00 |
| Sep 30, 2023 | -620,000.00 |
| Mar 31, 2021 | -446,000.00 |
| Mar 31, 2021 | -446,000.00 |